SlideShare a Scribd company logo
1 of 32
Download to read offline
Assurance Dépendance
2
Long-Term Care Insurance
1 Introduction
2 Caractéristiques des produits
3 The CIRDAD
4 Technical Issues
5 Underwriting selection and claims management
3
What is LTC (Loss of Autonomy)?
 The concept of Loss of Autonomy (LTC) can be defined based on 3 different notions :
 Functional limitations: caused by impairment in functional functions (walking for instance), in sensory development or in
cognitive disorders;
 Restrictions in activity: measured by ADL or IADL
 Need of help or assistance
 One definition of the Loss of Autonomy:
“Illness or ageing may generate functional limitations which, if not compensated by technical aids or environment
management, could lead to activity restrictions. This will lead to a regular assistance of a third person for the basic activities”
 LTC is neither Disability Insurance nor Health Insurance even if it is triggered by the same causes
 Disability is a reduction of capacity to accomplish an activity normally (World Health Organization definition)
 LTC is a limitation in the accomplishment of a normal role for age resulting from an impairment or disability
 LTC is defined by the inability to perform the Activities of Daily Living:
Bathing Dressing Continence
Eating Walking Bed-chair transfer
 Other scales – often public schemes - also use Instrumental Activities of Daily Living (more complex : domestic
activities, managing of the financial affairs, phoning…) or Superior Activities (interaction with social background:
leisure, sport, clubs, travels,…)
 Determining factors are numerous and various:
 The ageing of the population in the developed countries
 Actual or perceived role of the family assistance
 Actual or perceived role of the public schemes
4
The ageing of the population in developed countries
 An inevitable ageing of population: an increasing ratio of over 65 years old
Percentage of people over 65 in the population
10%
15%
20%
25%
30%
2000 2010 2020 2030
Italy
Spain
Germany
France
USA
Source : EUROSTAT, DREES-OFCE and U.S. Bureau of the Census, current Population Reports
5
Introduction
Demography in France – Main figures
 In 2005, 1 in 5 is over 60
 In 2050, 1 in 3 will be over 60
 The number of people over 60 will double
And…
 The number of people over 75 will be tripled
 The number of people over 85 will be
multiplied by 4
Actual or perceived role of the family
support
 Only 40% of French dependent people are
assisted by their family
 The Spanish and the Japanese cases are far
from this situation with more than 70-65%
assisted by family.
 The number of natural home helps (spouse,
children, neighborhood) will drop in France
from 2,5 to 2,1 persons by 2040 as:
 The average size of the family is
decreasing
 The age of fertility is increasing, reducing
the age and the availability of the
children at moment of LTC occurrence
 The labor participation of young and
middle-aged women is rising
5
6
Introduction
The role of the public schemes is
fundamental for the development of
private insurance :
 Communication around the new public
scheme, APA, in France strongly
boosted a sleepy LTCI market in 2002…
 …nevertheless, a very generous plan
can reduce the place of the private
market (Germany, Japan)
 Current governmental reflections
about the new branch of Social Security
for LTC and the Alzheimer plan should
be the main LTC growth’s driver
LTC: a common problem for developed
countries:
 Life Expectancy of elderly people has
increased
 Healthy Life Expectancy without severe
disability
 Life Expectancy with severe disability
 One of the biggest threats to the wealth of
the elderly
 Only 15% of people think they can cover the
costs of LTC
 Long-Term Care funding
 Shortfall of State benefits: large need of
cover to face long-term care
 related costs
Strong opportunities for
development of private Insurance
6
7
The LTC framework in France
 The average cost of LTC per person: EUR 2,500 to 3,000 per month
 The average pension, which is about EUR 1,200 per month
 Public scheme APA: EUR 491 monthly average APA
Gap to be financed: average EUR 1,500 per month
8
Long-Term Care Insurance
1 Introduction
2 Caractéristiques des produits
3 The CIRDAD
4 Technical Issues
5 Underwriting selection and claims management
9
The French v.s. US market
There are 2 main product designs : the reimbursement design and the cash benefit design
SGL operates only in cash benefit design
USA FRANCE
Public scheme Medicaid / Medicare PSD then APA
Experience ~ 30 years ~ 25 years
Annual Market Growth <0 p.a. on 2003-2012
+ 15-20% p.a. until
2006, stand still after
Current Market size
More than 7 million
insured in-force
More than 6 million
insured in-force
Products / Benefits
Mostly reimbursement
(of care services)
Cash benefits
The US approach:
 Currently mainly reimbursement, aiming at
covering all the costs
 Thus complex products to design, expensive
and difficult to monitor and administer
 In practice: low flexibility / inception options,
limited durations, inflation issue, lapses
issue, technical rate issue, price increases
 LTCI Market: adjusting for many years (still
ongoing)
The French approach:
 Coverage of severe impairments, now extending to less severe
ones
 Simple to sell and administer - monitorable (large consistent
experience)
 In practice: flexibility due to cash benefit, but
generally does not cover the full cost of LTC
and does not fit into the actual need of services
 LTCI Market: needs a real new life (some products launched)
10
Group vs Individual Insurance
Individual product Group: compulsory application
Application Optional Compulsory
Benefit level Choice between several guarantees with recommended limits Same benefits for each member
Entry age Usually between 40 y.o. and 75 y.o. Implicit limits
Deferred period Usually 90 days, absolute or relative Usually 90 days, absolute or relative
Medical underwritting Systematic No, if sufficiently large group
Elimination period Depends on the country but usually 3, 1 or 0 years No, if sufficiently large group
Duration of the cover Usually lifetime Annual
Premiums
Level premium
(based on the entry age)
Risk premiums
Reviewable premiums Usually yes Yes
Paid-up value Depends on the country No
Surrender value No No
Reserving
Premium reserve: reserve for increasing risk
Reserve for annuities in payment
Reserve for annuities in payment
Police termination
Annuities in payment are still paid
Paid-up value for the other insured
Only annuities in payment are still paid
11
Level premium and risk premium
 Whole life level premium
 Depends on the age at inception
 To be paid until claim payment or death
 Revisable rate (according to the technical results, medical treatment improvements and extended lifespan)
 Mainly for individual coverage or group enterprise coverage with a complementary individual cover
 Risk premium
 Annual coverage
 Depends of the age. Could be mutualized, but as long as there’s enough young insured to balance portfolio
ageing.
 Independent of time spend in the contract
 Mainly for statutory coverage of French Mutual or some group enterprise coverage
12
Example of pricing (French market)
 Annual premiums (net of any loadings)
 3 months deferred period
 Elimination period: 3, 1 or 0 years
 1000€ per month
 Total Loss of Autonomy
Levelled Premium Risk Premium
55yo 330 € 20 €
65yo 500 € 40 €
75yo 840 € 220 €
€-
€500,00
€1 000,00
€1 500,00
€2 000,00
€2 500,00 Comparison Risk and level premiums
Pure RP
Pure LP 60 yo
Pure LP 70 yo
Pure LP 75 yo
Pure LP 80 yo
Pure LP 85 yo
13
Riders and services
 Riders:
 « Equipment » Lump sum
 « Help for the caregiver » Lump sum (Group coverage)
 « Rest for the caregiver » Lump sum (Individual coverage)
 « Fracture » Lump sum
 « Death of the caregiver » Lump sum
 Services through Assistance contracts, for instance:
 At inception date: info and advices on everyday life (meal delivery, domestic help …), « life » check up »,
support in case of LoA of a relative (help for administrative process, search for long-term care facility, search for
psychological help …), prevention check up (Home adaptation …), memory check up …
 In case of partial LoAI: home adaptation, medicine delivery, teleassistance (to be connected with the outside
world), support for memory ….
 In case of total LoAI: support for life organization and quality of life, support for moving…
 Creation of a complete website on LTC
 …
14
Long-Term Care Insurance
1 Introduction
2 Caractéristiques des produits
3 The CIRDAD
4 Technical Issues
5 Underwriting selection and claims management
15
CIRDAD – A dedicated R&D Center for LTC
LTCI Portfolios (an important database)
Pricing basis / Risk Monitoring
New products
CIRDAD
Experience
Research
CIRDAD
16
CIRDAD: Statistical data
 What do we need to know to estimate the price of LTC ?
 How long do people live?
 How many will need LTC insurance?
 How long will the period of LTC last?
 Estimation of transition probabilities
 Large portfolios of homogeneous insurance data (25 years experience)
• Aggregate reliable data
• Combined experience of more than 30 million exposure-years and around 55 000 claims
 Population data, Specific studies and surveys
 Partnership with PAQUID (INSERM)
 LTC Risk Analysis for elderly: Survey of the French National Institute of Health and Medical Research (INSERM)
 Epidemiological study dedicated to ageing and its related pathologies
 A cohort survey, 20 years of follow-up
 PAQUID’s Relevance for Insurance
 Long-Term Care Risk Definitions
 Data, Prevalence of severe and moderate disability for very old people
17
Long-Term Care Insurance
1 Introduction
2 Caractéristiques des produits
3 The CIRDAD
4 Technical Issues
5 Underwriting selection and claims management
18
Technical issues – Statistical data
 3 transition probabilities
 Longevity of active people
 Depends on age, sex, life expectancy without severe disability
 Incidence of dependence
 Depends on age, sex, the medical selection effect
 Longevity of dependent people
 Depends on age, sex, time aalready spent in LTC, the main disease responsible for dependence
19
Technical issues – Semi-Markov Model used by Scor Global Life
aa
xq
0ia
xp
Healthy
Dead
Loss of autonomy
i
txq ,
i
xP
aa
xP
xi
20
Technical issues – Pricing
 Single pure premium for 1 unit of annuity in the event of total dependence (without taking waiting
time into account)
 The risk is differentiated by sex but the premiums are the same for both sexes (M/F proportions)
 Effect of selection, waiting periods, return of premium taken into account in the rate
 




0
,,
...
k
Smi
kx
S
kx
Saa
xk
kS
x aipv
sexS
ageentryx


21
Technical issues – Reserving
 Reserve for active people
 Prospective method, using pricing basis
 Unisex
 General formula :
 Reserves for outstanding claims
 Depends on age at the beginning of LTC, sex and time already spent in LTC
 General formula :



 
0
)'()(
.. "1)1.(..
j
maa
kx
mi
jkxjkx
aa
kxj
j
xk .äg).P(rRaipvPRC
premiumgrossP
investmentonreturnandensesforloadingg
ensespaymentannuityr
annuityannualR
durationoncontributikageentryx





"
exp
exp
,
   rRaPSAP Smi
tx
S
xt   1..,
ensespaymentannuityr
sexS
durationdependencytagedependencyx
exp
,



22
Technical issues – Reserving
 Equalization fund
 Reserve intended to smooth the bottom line over time
 Supplied by a percentage of the profits
 In order to offset potential future losses
 Permit to postpone/avoid a repricing
 After the fund reaches a certain level, the profits of the following years are totally shared
 Not deductible from the profits (depends on the country)
23
Technical issues – Statistical analysis
 Regular statistical analysis
 Analysis by underwriting generation
 Impact of selection and elimination period: masking effect
Monitoring
 Differences between pricing assumptions and experience
 Monitoring incidence and longevity (dependent and independent people)
 Adapting actuarial basis to the underwriting and acceptance of the insurer
24
Scénario:
- Shock on incidence rates : -10%
- No shock on autonomous mortality rates
- Shock on mortality rates for LTC people : -6%
In reality, staying with the initial actuarial basis
gives this wrong image of current results.
Statistical approach vs accounting approach
On the surface, the results are in surplus during
more than 20 years.
Pricing is at the good level
(almost the same than if there was no shock)
25
6. Sensitivities
Sensitivities on level premiums (last SGL’s biometric laws and deffered period of 3 months)
To offset simultaneous decrease by 10% in mortality of autonomous insured and of dependant insured,
the incidence should decrease by:
 18% for the annuity in case of Total LTC
 11% for the lump sum in case of Total LTC
 16% for the annuity in case of Total and Partial LTC
 10% for the lump sum in case of Total and Partial LTC
Total LTC Total and Partial LTC
Entry age 55 y.o. 65 y.o. 55 y.o. 65 y.o.
Annuity
1200 €/y
Lump
Sum
1000 €
Annuity
1200 €/y
Lump
Sum
1000 €
Annuity
1200 €/y
Lump
Sum
1000 €
Annuity
1200 €/y
Lump
Sum
1000 €
Incidence +10% +7% +6% +7% +6% 7% +5% +7% +6%
Incidence -10% -8% -6% -8% -6% -8% -6% -8% -6%
Mortality of
autonomous
-10% +4% +5% +3% +5% +3% +5% +2% +4%
Mortality of
Claimants
-10% +13% +1% +13% 1% +11% +1% +11% +1%
26
Reinsurance Offer
 Classical Quota-share treaty per generation:
 min retention: 20%
 ideally: 50%
 Commercial premium + reinsurance commission
 We help the ceding company concerning:
 The construction of the product
 The medical underwriting (process, analysis, … )
 The piloting of the portfolio following (pricing, reserves, … )
 The claims follow-up
27
Long-Term Care Insurance
1 Introduction
2 Caractéristiques des produits
3 The CIRDAD
4 Technical Issues
5 Underwriting selection and claims management
28
Underwriting selection: 2 stages
 Stage 1: Medical questionnaire filled in by the proposer
 Simple, rapid and easily completed
 Detection of preexisting disability or long term treatment
 a key monitoring tool
 If the proposer answers «NO» to all questions: acceptance at standard conditions
 Selection can stop here: about 55% of proposals are insured at standard rates
and the others are refused
 But possibility to study Substandard Risks with assessment of aggravating pathologies
 Stage 2: Specific Medical Questionnaire completed by the doctor
 More detailed, with specific questions
 Family history
 Lifestyle
 Existing pathologies and risk factors
29
Underwriting selection: The selection by SCOR Global Life
Standard risk: Medical Questionnaire without anomalies
Substandard Risk: assessment of extrapremium
Postponement: pathologies in evolution
or not consolidated
Refusal: already dependent or foreseeable long term care in
a near future
Long Term Care
30
Underwriting selection: The selection by SCOR Global Life
 Medical Risk Underwriting Manual:
 LTC substandard risk: more than 15 years of experience
 Solem: Computerization of Long Term Care
Underwriting Manual
 An original method
 A rapid solution obtained by the user
 Evolution and regular updating of underwriting bases according to our experience
 An additional protection: the elimination period
 Accident risk: 0
 Illness risk: 1 year
 Dementia risk: 3 years
 A safeguard against adverse selection
31
Claims management
 Verification of medical and administrative criteria
 Administrative: date of the beginning of the long term care – elimination period and deferred period
 Medical:
 Total or partial dependency must be permanent and irreversible
 Incapacity to perform 3 of 4 ADL (depending on the definition of the trigger in the contract)
 Confirmed dementia (MMSE or Folstein’s test)
 Need of a helper
Thanks for your attention

More Related Content

Viewers also liked

Confidentialité des données michel béra
Confidentialité des données   michel béraConfidentialité des données   michel béra
Confidentialité des données michel béraKezhan SHI
 
L'émergence d'une nouvelle filière de formation : data science
L'émergence d'une nouvelle filière de formation : data scienceL'émergence d'une nouvelle filière de formation : data science
L'émergence d'une nouvelle filière de formation : data scienceKezhan SHI
 
Arbres de régression et modèles de durée
Arbres de régression et modèles de duréeArbres de régression et modèles de durée
Arbres de régression et modèles de duréeKezhan SHI
 
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des Actuaires
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des ActuairesNorme IFRS - Pierre Thérond - Université d'été de l'Institut des Actuaires
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des ActuairesKezhan SHI
 
Eurocroissance arnaud cohen
Eurocroissance arnaud cohenEurocroissance arnaud cohen
Eurocroissance arnaud cohenKezhan SHI
 
Loi hamon sébastien bachellier
Loi hamon sébastien bachellierLoi hamon sébastien bachellier
Loi hamon sébastien bachellierKezhan SHI
 
Présentation Françoise Soulié Fogelman
Présentation Françoise Soulié FogelmanPrésentation Françoise Soulié Fogelman
Présentation Françoise Soulié FogelmanKezhan SHI
 
Big data en (ré)assurance régis delayet
Big data en (ré)assurance   régis delayetBig data en (ré)assurance   régis delayet
Big data en (ré)assurance régis delayetKezhan SHI
 
Big data analytics focus technique et nouvelles perspectives pour les actuaires
Big data analytics focus technique et nouvelles perspectives pour les actuairesBig data analytics focus technique et nouvelles perspectives pour les actuaires
Big data analytics focus technique et nouvelles perspectives pour les actuairesKezhan SHI
 

Viewers also liked (9)

Confidentialité des données michel béra
Confidentialité des données   michel béraConfidentialité des données   michel béra
Confidentialité des données michel béra
 
L'émergence d'une nouvelle filière de formation : data science
L'émergence d'une nouvelle filière de formation : data scienceL'émergence d'une nouvelle filière de formation : data science
L'émergence d'une nouvelle filière de formation : data science
 
Arbres de régression et modèles de durée
Arbres de régression et modèles de duréeArbres de régression et modèles de durée
Arbres de régression et modèles de durée
 
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des Actuaires
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des ActuairesNorme IFRS - Pierre Thérond - Université d'été de l'Institut des Actuaires
Norme IFRS - Pierre Thérond - Université d'été de l'Institut des Actuaires
 
Eurocroissance arnaud cohen
Eurocroissance arnaud cohenEurocroissance arnaud cohen
Eurocroissance arnaud cohen
 
Loi hamon sébastien bachellier
Loi hamon sébastien bachellierLoi hamon sébastien bachellier
Loi hamon sébastien bachellier
 
Présentation Françoise Soulié Fogelman
Présentation Françoise Soulié FogelmanPrésentation Françoise Soulié Fogelman
Présentation Françoise Soulié Fogelman
 
Big data en (ré)assurance régis delayet
Big data en (ré)assurance   régis delayetBig data en (ré)assurance   régis delayet
Big data en (ré)assurance régis delayet
 
Big data analytics focus technique et nouvelles perspectives pour les actuaires
Big data analytics focus technique et nouvelles perspectives pour les actuairesBig data analytics focus technique et nouvelles perspectives pour les actuaires
Big data analytics focus technique et nouvelles perspectives pour les actuaires
 

Similar to Les enjeux de la dépendance – laure de montesquieu, scor

2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)
2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)
2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)OECD_NAEC
 
Takaful in the Mediterranean Coming of Age by Mukti Ramli - II Islamic Finan...
Takaful in the Mediterranean Coming of Age by Mukti Ramli  - II Islamic Finan...Takaful in the Mediterranean Coming of Age by Mukti Ramli  - II Islamic Finan...
Takaful in the Mediterranean Coming of Age by Mukti Ramli - II Islamic Finan...ASCAME
 
Long term care - is private insurance possible in the UK?
Long term care - is private insurance possible in the UK?Long term care - is private insurance possible in the UK?
Long term care - is private insurance possible in the UK?kleer51
 
G7 high-level side event in Hiroshima
G7 high-level side event in HiroshimaG7 high-level side event in Hiroshima
G7 high-level side event in HiroshimaILC- UK
 
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...Ria Binst
 
12Oct16 - Housing in an Ageing Society
12Oct16 - Housing in an Ageing Society12Oct16 - Housing in an Ageing Society
12Oct16 - Housing in an Ageing SocietyILC- UK
 
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnership
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnershipILC-UK Seminar - The Private Sector's Role in Care - supported by partnership
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnershipILC- UK
 
Ht Presents Annuities To Napf South East Fin
Ht Presents Annuities To Napf South East   FinHt Presents Annuities To Napf South East   Fin
Ht Presents Annuities To Napf South East Finhenrytapper
 
mHealth Israel_French Health Insurance Overview_AXA Next
mHealth Israel_French Health Insurance Overview_AXA NextmHealth Israel_French Health Insurance Overview_AXA Next
mHealth Israel_French Health Insurance Overview_AXA NextLevi Shapiro
 
Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18NevinInstitute
 
Long-term care: Integrating health and social care - Albert Veraart, Netherlands
Long-term care: Integrating health and social care - Albert Veraart, NetherlandsLong-term care: Integrating health and social care - Albert Veraart, Netherlands
Long-term care: Integrating health and social care - Albert Veraart, NetherlandsOECD Governance
 
Aviva Mind The Gap survey regional uk pensions gap
Aviva Mind The Gap survey regional uk pensions gapAviva Mind The Gap survey regional uk pensions gap
Aviva Mind The Gap survey regional uk pensions gapcoussey
 
The preliminary plan_of_long-term_care_insurance
The preliminary plan_of_long-term_care_insuranceThe preliminary plan_of_long-term_care_insurance
The preliminary plan_of_long-term_care_insurancenobisyu
 
Case foruhc 1.sflb.ashx
Case foruhc 1.sflb.ashxCase foruhc 1.sflb.ashx
Case foruhc 1.sflb.ashxmelvin johnson
 

Similar to Les enjeux de la dépendance – laure de montesquieu, scor (20)

2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)
2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)
2014.01.10 - NAEC Seminar_Fostering long-term investment (Presentation 2)
 
Takaful in the Mediterranean Coming of Age by Mukti Ramli - II Islamic Finan...
Takaful in the Mediterranean Coming of Age by Mukti Ramli  - II Islamic Finan...Takaful in the Mediterranean Coming of Age by Mukti Ramli  - II Islamic Finan...
Takaful in the Mediterranean Coming of Age by Mukti Ramli - II Islamic Finan...
 
Long term care - is private insurance possible in the UK?
Long term care - is private insurance possible in the UK?Long term care - is private insurance possible in the UK?
Long term care - is private insurance possible in the UK?
 
20150428 LTCI scheme
20150428 LTCI scheme 20150428 LTCI scheme
20150428 LTCI scheme
 
G7 high-level side event in Hiroshima
G7 high-level side event in HiroshimaG7 high-level side event in Hiroshima
G7 high-level side event in Hiroshima
 
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...
Yuki Murakami (OESO) - De meerwaarde van ouderenzorg in België: een profielsc...
 
Pensions Core Course 2013: Adequacy and Sustainability of Contributory and No...
Pensions Core Course 2013: Adequacy and Sustainability of Contributory and No...Pensions Core Course 2013: Adequacy and Sustainability of Contributory and No...
Pensions Core Course 2013: Adequacy and Sustainability of Contributory and No...
 
12Oct16 - Housing in an Ageing Society
12Oct16 - Housing in an Ageing Society12Oct16 - Housing in an Ageing Society
12Oct16 - Housing in an Ageing Society
 
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnership
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnershipILC-UK Seminar - The Private Sector's Role in Care - supported by partnership
ILC-UK Seminar - The Private Sector's Role in Care - supported by partnership
 
Key findings from the 2016 OECD Pensions Outlook
Key findings from the 2016 OECD Pensions OutlookKey findings from the 2016 OECD Pensions Outlook
Key findings from the 2016 OECD Pensions Outlook
 
Ht Presents Annuities To Napf South East Fin
Ht Presents Annuities To Napf South East   FinHt Presents Annuities To Napf South East   Fin
Ht Presents Annuities To Napf South East Fin
 
mHealth Israel_French Health Insurance Overview_AXA Next
mHealth Israel_French Health Insurance Overview_AXA NextmHealth Israel_French Health Insurance Overview_AXA Next
mHealth Israel_French Health Insurance Overview_AXA Next
 
Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18
 
54230.pptx
54230.pptx54230.pptx
54230.pptx
 
Long-term care: Integrating health and social care - Albert Veraart, Netherlands
Long-term care: Integrating health and social care - Albert Veraart, NetherlandsLong-term care: Integrating health and social care - Albert Veraart, Netherlands
Long-term care: Integrating health and social care - Albert Veraart, Netherlands
 
Aviva Mind The Gap survey regional uk pensions gap
Aviva Mind The Gap survey regional uk pensions gapAviva Mind The Gap survey regional uk pensions gap
Aviva Mind The Gap survey regional uk pensions gap
 
Textile ETP: Next 10 years
Textile ETP: Next 10 yearsTextile ETP: Next 10 years
Textile ETP: Next 10 years
 
The preliminary plan_of_long-term_care_insurance
The preliminary plan_of_long-term_care_insuranceThe preliminary plan_of_long-term_care_insurance
The preliminary plan_of_long-term_care_insurance
 
Case foruhc 1.sflb.ashx
Case foruhc 1.sflb.ashxCase foruhc 1.sflb.ashx
Case foruhc 1.sflb.ashx
 
Health insurance1
Health insurance1Health insurance1
Health insurance1
 

More from Kezhan SHI

Big data fp prez nouv. formation_datascience_15-sept
Big data fp prez nouv. formation_datascience_15-septBig data fp prez nouv. formation_datascience_15-sept
Big data fp prez nouv. formation_datascience_15-septKezhan SHI
 
Big data fiche data science 15 09 14
Big data fiche data science 15 09 14Big data fiche data science 15 09 14
Big data fiche data science 15 09 14Kezhan SHI
 
Big data ads gouvernance ads v2[
Big data ads   gouvernance ads v2[Big data ads   gouvernance ads v2[
Big data ads gouvernance ads v2[Kezhan SHI
 
Big data f prez formation_datascience_14-sept
Big data f prez formation_datascience_14-septBig data f prez formation_datascience_14-sept
Big data f prez formation_datascience_14-septKezhan SHI
 
B -technical_specification_for_the_preparatory_phase__part_ii_
B  -technical_specification_for_the_preparatory_phase__part_ii_B  -technical_specification_for_the_preparatory_phase__part_ii_
B -technical_specification_for_the_preparatory_phase__part_ii_Kezhan SHI
 
A -technical_specification_for_the_preparatory_phase__part_i_
A  -technical_specification_for_the_preparatory_phase__part_i_A  -technical_specification_for_the_preparatory_phase__part_i_
A -technical_specification_for_the_preparatory_phase__part_i_Kezhan SHI
 
20140806 traduction hypotheses_sous-jacentes_formule_standard
20140806 traduction hypotheses_sous-jacentes_formule_standard20140806 traduction hypotheses_sous-jacentes_formule_standard
20140806 traduction hypotheses_sous-jacentes_formule_standardKezhan SHI
 
20140613 focus-specifications-techniques-2014
20140613 focus-specifications-techniques-201420140613 focus-specifications-techniques-2014
20140613 focus-specifications-techniques-2014Kezhan SHI
 
20140516 traduction spec_tech_eiopa_2014_bilan
20140516 traduction spec_tech_eiopa_2014_bilan20140516 traduction spec_tech_eiopa_2014_bilan
20140516 traduction spec_tech_eiopa_2014_bilanKezhan SHI
 
C -annexes_to_technical_specification_for_the_preparatory_phase__part_i_
C  -annexes_to_technical_specification_for_the_preparatory_phase__part_i_C  -annexes_to_technical_specification_for_the_preparatory_phase__part_i_
C -annexes_to_technical_specification_for_the_preparatory_phase__part_i_Kezhan SHI
 
Qis5 technical specifications-20100706
Qis5 technical specifications-20100706Qis5 technical specifications-20100706
Qis5 technical specifications-20100706Kezhan SHI
 
Directive solvabilité 2
Directive solvabilité 2Directive solvabilité 2
Directive solvabilité 2Kezhan SHI
 
Directive omnibus 2
Directive omnibus 2Directive omnibus 2
Directive omnibus 2Kezhan SHI
 
Tableau de comparaison bilan S1 et bilan S2
Tableau de comparaison bilan S1 et bilan S2Tableau de comparaison bilan S1 et bilan S2
Tableau de comparaison bilan S1 et bilan S2Kezhan SHI
 
Rapport d'activité 2013 - CNIL
Rapport d'activité 2013 - CNILRapport d'activité 2013 - CNIL
Rapport d'activité 2013 - CNILKezhan SHI
 
Xavier Milaud - Techniques d'arbres de classification et de régression
Xavier Milaud - Techniques d'arbres de classification et de régressionXavier Milaud - Techniques d'arbres de classification et de régression
Xavier Milaud - Techniques d'arbres de classification et de régressionKezhan SHI
 

More from Kezhan SHI (16)

Big data fp prez nouv. formation_datascience_15-sept
Big data fp prez nouv. formation_datascience_15-septBig data fp prez nouv. formation_datascience_15-sept
Big data fp prez nouv. formation_datascience_15-sept
 
Big data fiche data science 15 09 14
Big data fiche data science 15 09 14Big data fiche data science 15 09 14
Big data fiche data science 15 09 14
 
Big data ads gouvernance ads v2[
Big data ads   gouvernance ads v2[Big data ads   gouvernance ads v2[
Big data ads gouvernance ads v2[
 
Big data f prez formation_datascience_14-sept
Big data f prez formation_datascience_14-septBig data f prez formation_datascience_14-sept
Big data f prez formation_datascience_14-sept
 
B -technical_specification_for_the_preparatory_phase__part_ii_
B  -technical_specification_for_the_preparatory_phase__part_ii_B  -technical_specification_for_the_preparatory_phase__part_ii_
B -technical_specification_for_the_preparatory_phase__part_ii_
 
A -technical_specification_for_the_preparatory_phase__part_i_
A  -technical_specification_for_the_preparatory_phase__part_i_A  -technical_specification_for_the_preparatory_phase__part_i_
A -technical_specification_for_the_preparatory_phase__part_i_
 
20140806 traduction hypotheses_sous-jacentes_formule_standard
20140806 traduction hypotheses_sous-jacentes_formule_standard20140806 traduction hypotheses_sous-jacentes_formule_standard
20140806 traduction hypotheses_sous-jacentes_formule_standard
 
20140613 focus-specifications-techniques-2014
20140613 focus-specifications-techniques-201420140613 focus-specifications-techniques-2014
20140613 focus-specifications-techniques-2014
 
20140516 traduction spec_tech_eiopa_2014_bilan
20140516 traduction spec_tech_eiopa_2014_bilan20140516 traduction spec_tech_eiopa_2014_bilan
20140516 traduction spec_tech_eiopa_2014_bilan
 
C -annexes_to_technical_specification_for_the_preparatory_phase__part_i_
C  -annexes_to_technical_specification_for_the_preparatory_phase__part_i_C  -annexes_to_technical_specification_for_the_preparatory_phase__part_i_
C -annexes_to_technical_specification_for_the_preparatory_phase__part_i_
 
Qis5 technical specifications-20100706
Qis5 technical specifications-20100706Qis5 technical specifications-20100706
Qis5 technical specifications-20100706
 
Directive solvabilité 2
Directive solvabilité 2Directive solvabilité 2
Directive solvabilité 2
 
Directive omnibus 2
Directive omnibus 2Directive omnibus 2
Directive omnibus 2
 
Tableau de comparaison bilan S1 et bilan S2
Tableau de comparaison bilan S1 et bilan S2Tableau de comparaison bilan S1 et bilan S2
Tableau de comparaison bilan S1 et bilan S2
 
Rapport d'activité 2013 - CNIL
Rapport d'activité 2013 - CNILRapport d'activité 2013 - CNIL
Rapport d'activité 2013 - CNIL
 
Xavier Milaud - Techniques d'arbres de classification et de régression
Xavier Milaud - Techniques d'arbres de classification et de régressionXavier Milaud - Techniques d'arbres de classification et de régression
Xavier Milaud - Techniques d'arbres de classification et de régression
 

Recently uploaded

Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxnelietumpap1
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 

Recently uploaded (20)

Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 

Les enjeux de la dépendance – laure de montesquieu, scor

  • 2. 2 Long-Term Care Insurance 1 Introduction 2 Caractéristiques des produits 3 The CIRDAD 4 Technical Issues 5 Underwriting selection and claims management
  • 3. 3 What is LTC (Loss of Autonomy)?  The concept of Loss of Autonomy (LTC) can be defined based on 3 different notions :  Functional limitations: caused by impairment in functional functions (walking for instance), in sensory development or in cognitive disorders;  Restrictions in activity: measured by ADL or IADL  Need of help or assistance  One definition of the Loss of Autonomy: “Illness or ageing may generate functional limitations which, if not compensated by technical aids or environment management, could lead to activity restrictions. This will lead to a regular assistance of a third person for the basic activities”  LTC is neither Disability Insurance nor Health Insurance even if it is triggered by the same causes  Disability is a reduction of capacity to accomplish an activity normally (World Health Organization definition)  LTC is a limitation in the accomplishment of a normal role for age resulting from an impairment or disability  LTC is defined by the inability to perform the Activities of Daily Living: Bathing Dressing Continence Eating Walking Bed-chair transfer  Other scales – often public schemes - also use Instrumental Activities of Daily Living (more complex : domestic activities, managing of the financial affairs, phoning…) or Superior Activities (interaction with social background: leisure, sport, clubs, travels,…)  Determining factors are numerous and various:  The ageing of the population in the developed countries  Actual or perceived role of the family assistance  Actual or perceived role of the public schemes
  • 4. 4 The ageing of the population in developed countries  An inevitable ageing of population: an increasing ratio of over 65 years old Percentage of people over 65 in the population 10% 15% 20% 25% 30% 2000 2010 2020 2030 Italy Spain Germany France USA Source : EUROSTAT, DREES-OFCE and U.S. Bureau of the Census, current Population Reports
  • 5. 5 Introduction Demography in France – Main figures  In 2005, 1 in 5 is over 60  In 2050, 1 in 3 will be over 60  The number of people over 60 will double And…  The number of people over 75 will be tripled  The number of people over 85 will be multiplied by 4 Actual or perceived role of the family support  Only 40% of French dependent people are assisted by their family  The Spanish and the Japanese cases are far from this situation with more than 70-65% assisted by family.  The number of natural home helps (spouse, children, neighborhood) will drop in France from 2,5 to 2,1 persons by 2040 as:  The average size of the family is decreasing  The age of fertility is increasing, reducing the age and the availability of the children at moment of LTC occurrence  The labor participation of young and middle-aged women is rising 5
  • 6. 6 Introduction The role of the public schemes is fundamental for the development of private insurance :  Communication around the new public scheme, APA, in France strongly boosted a sleepy LTCI market in 2002…  …nevertheless, a very generous plan can reduce the place of the private market (Germany, Japan)  Current governmental reflections about the new branch of Social Security for LTC and the Alzheimer plan should be the main LTC growth’s driver LTC: a common problem for developed countries:  Life Expectancy of elderly people has increased  Healthy Life Expectancy without severe disability  Life Expectancy with severe disability  One of the biggest threats to the wealth of the elderly  Only 15% of people think they can cover the costs of LTC  Long-Term Care funding  Shortfall of State benefits: large need of cover to face long-term care  related costs Strong opportunities for development of private Insurance 6
  • 7. 7 The LTC framework in France  The average cost of LTC per person: EUR 2,500 to 3,000 per month  The average pension, which is about EUR 1,200 per month  Public scheme APA: EUR 491 monthly average APA Gap to be financed: average EUR 1,500 per month
  • 8. 8 Long-Term Care Insurance 1 Introduction 2 Caractéristiques des produits 3 The CIRDAD 4 Technical Issues 5 Underwriting selection and claims management
  • 9. 9 The French v.s. US market There are 2 main product designs : the reimbursement design and the cash benefit design SGL operates only in cash benefit design USA FRANCE Public scheme Medicaid / Medicare PSD then APA Experience ~ 30 years ~ 25 years Annual Market Growth <0 p.a. on 2003-2012 + 15-20% p.a. until 2006, stand still after Current Market size More than 7 million insured in-force More than 6 million insured in-force Products / Benefits Mostly reimbursement (of care services) Cash benefits The US approach:  Currently mainly reimbursement, aiming at covering all the costs  Thus complex products to design, expensive and difficult to monitor and administer  In practice: low flexibility / inception options, limited durations, inflation issue, lapses issue, technical rate issue, price increases  LTCI Market: adjusting for many years (still ongoing) The French approach:  Coverage of severe impairments, now extending to less severe ones  Simple to sell and administer - monitorable (large consistent experience)  In practice: flexibility due to cash benefit, but generally does not cover the full cost of LTC and does not fit into the actual need of services  LTCI Market: needs a real new life (some products launched)
  • 10. 10 Group vs Individual Insurance Individual product Group: compulsory application Application Optional Compulsory Benefit level Choice between several guarantees with recommended limits Same benefits for each member Entry age Usually between 40 y.o. and 75 y.o. Implicit limits Deferred period Usually 90 days, absolute or relative Usually 90 days, absolute or relative Medical underwritting Systematic No, if sufficiently large group Elimination period Depends on the country but usually 3, 1 or 0 years No, if sufficiently large group Duration of the cover Usually lifetime Annual Premiums Level premium (based on the entry age) Risk premiums Reviewable premiums Usually yes Yes Paid-up value Depends on the country No Surrender value No No Reserving Premium reserve: reserve for increasing risk Reserve for annuities in payment Reserve for annuities in payment Police termination Annuities in payment are still paid Paid-up value for the other insured Only annuities in payment are still paid
  • 11. 11 Level premium and risk premium  Whole life level premium  Depends on the age at inception  To be paid until claim payment or death  Revisable rate (according to the technical results, medical treatment improvements and extended lifespan)  Mainly for individual coverage or group enterprise coverage with a complementary individual cover  Risk premium  Annual coverage  Depends of the age. Could be mutualized, but as long as there’s enough young insured to balance portfolio ageing.  Independent of time spend in the contract  Mainly for statutory coverage of French Mutual or some group enterprise coverage
  • 12. 12 Example of pricing (French market)  Annual premiums (net of any loadings)  3 months deferred period  Elimination period: 3, 1 or 0 years  1000€ per month  Total Loss of Autonomy Levelled Premium Risk Premium 55yo 330 € 20 € 65yo 500 € 40 € 75yo 840 € 220 € €- €500,00 €1 000,00 €1 500,00 €2 000,00 €2 500,00 Comparison Risk and level premiums Pure RP Pure LP 60 yo Pure LP 70 yo Pure LP 75 yo Pure LP 80 yo Pure LP 85 yo
  • 13. 13 Riders and services  Riders:  « Equipment » Lump sum  « Help for the caregiver » Lump sum (Group coverage)  « Rest for the caregiver » Lump sum (Individual coverage)  « Fracture » Lump sum  « Death of the caregiver » Lump sum  Services through Assistance contracts, for instance:  At inception date: info and advices on everyday life (meal delivery, domestic help …), « life » check up », support in case of LoA of a relative (help for administrative process, search for long-term care facility, search for psychological help …), prevention check up (Home adaptation …), memory check up …  In case of partial LoAI: home adaptation, medicine delivery, teleassistance (to be connected with the outside world), support for memory ….  In case of total LoAI: support for life organization and quality of life, support for moving…  Creation of a complete website on LTC  …
  • 14. 14 Long-Term Care Insurance 1 Introduction 2 Caractéristiques des produits 3 The CIRDAD 4 Technical Issues 5 Underwriting selection and claims management
  • 15. 15 CIRDAD – A dedicated R&D Center for LTC LTCI Portfolios (an important database) Pricing basis / Risk Monitoring New products CIRDAD Experience Research CIRDAD
  • 16. 16 CIRDAD: Statistical data  What do we need to know to estimate the price of LTC ?  How long do people live?  How many will need LTC insurance?  How long will the period of LTC last?  Estimation of transition probabilities  Large portfolios of homogeneous insurance data (25 years experience) • Aggregate reliable data • Combined experience of more than 30 million exposure-years and around 55 000 claims  Population data, Specific studies and surveys  Partnership with PAQUID (INSERM)  LTC Risk Analysis for elderly: Survey of the French National Institute of Health and Medical Research (INSERM)  Epidemiological study dedicated to ageing and its related pathologies  A cohort survey, 20 years of follow-up  PAQUID’s Relevance for Insurance  Long-Term Care Risk Definitions  Data, Prevalence of severe and moderate disability for very old people
  • 17. 17 Long-Term Care Insurance 1 Introduction 2 Caractéristiques des produits 3 The CIRDAD 4 Technical Issues 5 Underwriting selection and claims management
  • 18. 18 Technical issues – Statistical data  3 transition probabilities  Longevity of active people  Depends on age, sex, life expectancy without severe disability  Incidence of dependence  Depends on age, sex, the medical selection effect  Longevity of dependent people  Depends on age, sex, time aalready spent in LTC, the main disease responsible for dependence
  • 19. 19 Technical issues – Semi-Markov Model used by Scor Global Life aa xq 0ia xp Healthy Dead Loss of autonomy i txq , i xP aa xP xi
  • 20. 20 Technical issues – Pricing  Single pure premium for 1 unit of annuity in the event of total dependence (without taking waiting time into account)  The risk is differentiated by sex but the premiums are the same for both sexes (M/F proportions)  Effect of selection, waiting periods, return of premium taken into account in the rate       0 ,, ... k Smi kx S kx Saa xk kS x aipv sexS ageentryx  
  • 21. 21 Technical issues – Reserving  Reserve for active people  Prospective method, using pricing basis  Unisex  General formula :  Reserves for outstanding claims  Depends on age at the beginning of LTC, sex and time already spent in LTC  General formula :      0 )'()( .. "1)1.(.. j maa kx mi jkxjkx aa kxj j xk .äg).P(rRaipvPRC premiumgrossP investmentonreturnandensesforloadingg ensespaymentannuityr annuityannualR durationoncontributikageentryx      " exp exp ,    rRaPSAP Smi tx S xt   1.., ensespaymentannuityr sexS durationdependencytagedependencyx exp ,   
  • 22. 22 Technical issues – Reserving  Equalization fund  Reserve intended to smooth the bottom line over time  Supplied by a percentage of the profits  In order to offset potential future losses  Permit to postpone/avoid a repricing  After the fund reaches a certain level, the profits of the following years are totally shared  Not deductible from the profits (depends on the country)
  • 23. 23 Technical issues – Statistical analysis  Regular statistical analysis  Analysis by underwriting generation  Impact of selection and elimination period: masking effect Monitoring  Differences between pricing assumptions and experience  Monitoring incidence and longevity (dependent and independent people)  Adapting actuarial basis to the underwriting and acceptance of the insurer
  • 24. 24 Scénario: - Shock on incidence rates : -10% - No shock on autonomous mortality rates - Shock on mortality rates for LTC people : -6% In reality, staying with the initial actuarial basis gives this wrong image of current results. Statistical approach vs accounting approach On the surface, the results are in surplus during more than 20 years. Pricing is at the good level (almost the same than if there was no shock)
  • 25. 25 6. Sensitivities Sensitivities on level premiums (last SGL’s biometric laws and deffered period of 3 months) To offset simultaneous decrease by 10% in mortality of autonomous insured and of dependant insured, the incidence should decrease by:  18% for the annuity in case of Total LTC  11% for the lump sum in case of Total LTC  16% for the annuity in case of Total and Partial LTC  10% for the lump sum in case of Total and Partial LTC Total LTC Total and Partial LTC Entry age 55 y.o. 65 y.o. 55 y.o. 65 y.o. Annuity 1200 €/y Lump Sum 1000 € Annuity 1200 €/y Lump Sum 1000 € Annuity 1200 €/y Lump Sum 1000 € Annuity 1200 €/y Lump Sum 1000 € Incidence +10% +7% +6% +7% +6% 7% +5% +7% +6% Incidence -10% -8% -6% -8% -6% -8% -6% -8% -6% Mortality of autonomous -10% +4% +5% +3% +5% +3% +5% +2% +4% Mortality of Claimants -10% +13% +1% +13% 1% +11% +1% +11% +1%
  • 26. 26 Reinsurance Offer  Classical Quota-share treaty per generation:  min retention: 20%  ideally: 50%  Commercial premium + reinsurance commission  We help the ceding company concerning:  The construction of the product  The medical underwriting (process, analysis, … )  The piloting of the portfolio following (pricing, reserves, … )  The claims follow-up
  • 27. 27 Long-Term Care Insurance 1 Introduction 2 Caractéristiques des produits 3 The CIRDAD 4 Technical Issues 5 Underwriting selection and claims management
  • 28. 28 Underwriting selection: 2 stages  Stage 1: Medical questionnaire filled in by the proposer  Simple, rapid and easily completed  Detection of preexisting disability or long term treatment  a key monitoring tool  If the proposer answers «NO» to all questions: acceptance at standard conditions  Selection can stop here: about 55% of proposals are insured at standard rates and the others are refused  But possibility to study Substandard Risks with assessment of aggravating pathologies  Stage 2: Specific Medical Questionnaire completed by the doctor  More detailed, with specific questions  Family history  Lifestyle  Existing pathologies and risk factors
  • 29. 29 Underwriting selection: The selection by SCOR Global Life Standard risk: Medical Questionnaire without anomalies Substandard Risk: assessment of extrapremium Postponement: pathologies in evolution or not consolidated Refusal: already dependent or foreseeable long term care in a near future Long Term Care
  • 30. 30 Underwriting selection: The selection by SCOR Global Life  Medical Risk Underwriting Manual:  LTC substandard risk: more than 15 years of experience  Solem: Computerization of Long Term Care Underwriting Manual  An original method  A rapid solution obtained by the user  Evolution and regular updating of underwriting bases according to our experience  An additional protection: the elimination period  Accident risk: 0  Illness risk: 1 year  Dementia risk: 3 years  A safeguard against adverse selection
  • 31. 31 Claims management  Verification of medical and administrative criteria  Administrative: date of the beginning of the long term care – elimination period and deferred period  Medical:  Total or partial dependency must be permanent and irreversible  Incapacity to perform 3 of 4 ADL (depending on the definition of the trigger in the contract)  Confirmed dementia (MMSE or Folstein’s test)  Need of a helper
  • 32. Thanks for your attention